- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Mouse Lab Getting Personal, Sniffs Florida Digs
16 October 2009 3:24 pm
The Jackson Laboratory, the mouse-research powerhouse in Bar Harbor, Maine, is thinking about building a branch in south Florida as part of a move into personalized medicine.
The nonprofit Jax is best known for basic genetics research and its resource of more than 4000 strains of mice. As DNA sequencing costs have dropped, the lab now wants to bridge mouse and human studies and "play a pioneering role in the science that will accelerate personalized medicine," says Jax CEO Richard Woychik. Another motivator is Florida's success at using financial incentives to lure major biomedical research centers, such as California's Scripps Research Institute, to establish outposts in the state. Jax spokesperson Barry Teater says the lab is "in discussions" with state and Collier County officials about a possible site near Naples in southwest Florida, where Jax's fundraising council has "a very active" chapter.
Although there is no major research university near Naples, Teater says that "near is relative" and that Jax is talking to universities and hospitals across Florida about potential collaborations that would give its researchers access to patients. The $100-million-a-year institute would have 200 employees and open by the end of 2013. Discussions are ongoing, Teater says; he expects a "go or no-go" decision by next summer.